Goldman Sachs initiated coverage on Sage Therapeutics (NASDAQ: SAGE) with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

New Coverage

Sage Therapeutics (SAGE) PT Raised to $70 at Leerink Partners as New Data Corroborates Prior Promising ResultsMay 14, 2015 11:03 AM Roth Capital Affirms Ligand Pharma (LGND) Following Positive SAGE-547 Update (SAGE)May 14, 2015 10:19 AM SAGE Therapeutics (SAGE) Misses Q1 EPS by 17cMay 14, 2015 6:33 AM SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial ResultsMay 14, 2015 6:30 AM